Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,286.68 +171.71 (+0.26%) CMC Crypto 200
1,374.33 -43.54 (-3.07%)
CBRE Sep 2024 87.500 put
| Previous close | 2.7500 |
| Open | 2.7500 |
| Bid | 4.0000 |
| Ask | 4.5000 |
| Strike | 87.50 |
| Expiry date | 2024-09-20 |
| Day's range | 2.7500 - 2.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 338 |
PR NewswireMainStay CBRE Global Infrastructure Megatrends Term Fund (NYSE: MEGI) Declares Monthly Distribution for June 2024 and Availability of 19(a) Notice
MainStay CBRE Global Infrastructure Megatrends Term Fund (the "Fund") (NYSE: MEGI) today announced the Fund's monthly distributions for June 2024 of $0.1250 per common share. The Fund's current annualized distribution rate is 11.79% based upon the closing price of $12.72 on June 12, 2024, and 10.32% based upon the Fund's closing NAV of $14.54 as of the same date.
Business WireCBRE Expands Climate Risk Assessment Capabilities with Climate X Agreement, Enabling Enhanced Actionable Sustainability Insights
DALLAS, June 13, 2024--CBRE Group, Inc. (NYSE:CBRE) today announced expanded capabilities to provide comprehensive climate risk data for property investors and occupiers to accelerate their sustainability planning, reporting and decision making.
EdgePropAgeing population, rising healthcare needs to fuel demand for Singapore life sciences real estate: CBRE
Life sciences real estate in Singapore are predominantly located in three clusters: Biopolis, Singapore Science Park and Tuas Biomedical Park (Picture: Samuel Isaac Chua/The Edge Singapore)The biomedical manufacturing sector is poised to see sustained growth, which in turn, will propel momentum for Singapore’s biomedical sector and consequently demand for R&D and specialised manufacturing spaces, according to CBRE.In a June research report, the consultancy highlights biomedical manufacturing’s s
